Immunogenicity 11033
Sample ID
3678
Response
Negative
Tumor Type
Melanoma
Gene Symbol
RBFA
Transcript ID
None
HLA INFO
C*14:02
TCR INFO
No TCR info found!
Full length protein sequence (343 aa)
MWAAA
1
GGLWR
6
SRAGL
11
RALFR
16
SRDAA
21
LFPGC
26
ERGLH
31
CSAVS
36
CKNWL
41
KKFAS
46
KTKKK
51
VWYES
56
PSLGS
61
HSTYK
66
PSKLE
71
FLMRS
76
TSKKT
81
RKEDH
86
ARLRA
91
LNGLL
96
YKALT
101
DLLCT
106
PEVSQ
111
ELYDL
116
NVELS
121
KVSLT
126
PDFSA
131
CRAYW
136
KTTLS
141
AEQNA
146
HMEAV
151
LQRSA
156
AHMRH
161
LLMSQ
166
QTLRN
171
VPPIV
176
FVQDK
181
GNAAL
186
AELDQ
191
LLAVA
196
DFGPR
201
DERDN
206
FVQND
211
FRDPD
216
APQPC
221
GTTEP
226
TTSSS
231
LCGID
236
HEALN
241
KQIME
246
YKRRK
251
DKGLG
256
GLVWQ
261
GQVAE
266
LTTQM
271
KKGRK
276
RAKPR
281
LEQDS
286
SLKSY
291
LSGEE
296
VEDDL
301
DLVGA
306
PEYEC
311
YAPDT
316
EELEA
321
ERGGG
326
RTEDG
331
HSCGA
336
SRE
341
Mutation Information
DNA mutation:
None
Peptide Range:
291 ~ 315
Mut AA position:
303 (13 in Wild Type peptide)
Alignment
Wild Type:
"SLKSYLSGEEVEDDLDLVGAPEYEC
||||||||||||.||||||||||||
Mutant:
SLKSYLSGEEVENDLDLVGAPEYEC"
Clin Cancer Res, 2017
Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 ExpressionGene Name (from Reference) RBFA
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
TILs
APC
Type
autologous DCs
Assay
ELISPOT assay